TCIM
FENC icon

TIAA CREF Investment Management’s Fennec Pharmaceuticals FENC Stock Holding History

TIAA CREF Investment Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$61K Buy
12,626
+1,993
+19% +$13.1K ﹤0.01% 2989
2018
Q4 		$68K Hold
10,633
– – ﹤0.01% 2985
2018
Q3 		$87K Sell
10,633
-6,746
-39% -$62.6K ﹤0.01% 3041
2018
Q2 		$181K Buy
+17,379
New +$206K ﹤0.01% 3043

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIAA CREF Investment Management's FENC Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Fennec Pharmaceuticals (FENC) stake by 19% in Q1 2019, buying an estimated $13.1K and bringing the position to 12,626 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #2989.

TIAA CREF Investment Management first reported a position in FENC in Q2 2018 and has held it in 4 quarters since. The position peaked at $181K in Q2 2018. 49 funds tracked by Wall St. Rank hold FENC as of Q1 2019.

  • TIAA CREF Investment Management held 12,626 shares of Fennec Pharmaceuticals worth $61K as of Q1 2019.
  • TIAA CREF Investment Management bought 1,993 Fennec Pharmaceuticals shares in Q1 2019, an estimated $13.1K.
  • Fennec Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2989 holding.
  • TIAA CREF Investment Management first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's Fennec Pharmaceuticals position peaked at $181K in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.